Welcome to LookChem.com Sign In|Join Free
  • or
1-Butamine 4-azide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

88192-20-5

Post Buying Request

88192-20-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

88192-20-5 Usage

Uses

4-Azidobutylamine is weakly or non-mutagenic to Salmonella typhimurium.

Check Digit Verification of cas no

The CAS Registry Mumber 88192-20-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,1,9 and 2 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 88192-20:
(7*8)+(6*8)+(5*1)+(4*9)+(3*2)+(2*2)+(1*0)=155
155 % 10 = 5
So 88192-20-5 is a valid CAS Registry Number.
InChI:InChI=1/C4H10N4/c5-3-1-2-4-7-8-6/h1-5H2

88192-20-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Azidobutan-1-amine

1.2 Other means of identification

Product number -
Other names 6-azidobutylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:88192-20-5 SDS

88192-20-5Synthetic route

1,4-diazidobutane
24345-72-0

1,4-diazidobutane

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

Conditions
ConditionsYield
With hydrogenchloride; triphenylphosphine In diethyl ether; water; ethyl acetate at 20℃; for 24h;88%
With hydrogenchloride; water; triphenylphosphine In diethyl ether; ethyl acetate at 0 - 20℃; for 25h;88%
With hydrogenchloride; triphenylphosphine In diethyl ether; water; ethyl acetate at 0 - 20℃; for 25h; Inert atmosphere;88%
1-azido-4-isocyanatobutane
177489-76-8

1-azido-4-isocyanatobutane

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

Conditions
ConditionsYield
With sodium hydroxide In tetrahydrofuran for 4h; Heating;83%
N-(4-azidobutyl)phthalimide
66917-06-4

N-(4-azidobutyl)phthalimide

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

Conditions
ConditionsYield
With hydrazine hydrate In ethanol for 24h;62%
With hydrazine hydrate In tetrahydrofuran at 60℃; for 4h;
With hydrazine In methanol Inert atmosphere;
1,4-diaminobutane
110-60-1

1,4-diaminobutane

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

Conditions
ConditionsYield
With triflic azide; potassium carbonate; copper(II) sulfate In methanol; water61%
1-chloro-4-aminobutane hydrochloride

1-chloro-4-aminobutane hydrochloride

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

Conditions
ConditionsYield
With sodium azide In water at 80℃; for 15h;50%
1,4-diaminobutane
110-60-1

1,4-diaminobutane

A

1,4-diazidobutane
24345-72-0

1,4-diazidobutane

B

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

Conditions
ConditionsYield
With triflic azide; potassium carbonate; copper(II) sulfate In water for 18h; Inert atmosphere;A 30%
B 40%
N-t-butoxycarbonyl-4-azidobutylamine
129392-85-4

N-t-butoxycarbonyl-4-azidobutylamine

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

Conditions
ConditionsYield
With hydrogenchloride In ethyl acetate at 20℃; for 72h;
With trifluoroacetic acid In dichloromethane at 20℃; for 16h;
1,4-diazidobutane
24345-72-0

1,4-diazidobutane

triphenylphosphine
603-35-0

triphenylphosphine

A

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

B

Triphenylphosphine oxide
791-28-6

Triphenylphosphine oxide

Conditions
ConditionsYield
With hydrogenchloride; water In diethyl ether; hexane at 0℃; modified Staudinger reaction;
1,4-dibromo-butane
110-52-1

1,4-dibromo-butane

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

Conditions
ConditionsYield
With sodium azide In water; N,N-dimethyl-formamide at 80 - 85℃; for 8h;343.7 g
Stage #1: 1,4-dibromo-butane With sodium azide In water; N,N-dimethyl-formamide at 80 - 90℃; for 12h;
Stage #2: With hydrogenchloride; triphenylphosphine In water at 25 - 35℃; for 12h;
1-bromo-4-aminobutane
33977-38-7

1-bromo-4-aminobutane

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

Conditions
ConditionsYield
With sodium azide In water at 80℃;620 mg
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

N-t-butoxycarbonyl-4-azidobutylamine
129392-85-4

N-t-butoxycarbonyl-4-azidobutylamine

Conditions
ConditionsYield
With sodium hydroxide In tetrahydrofuran; water100%
benzyl chloroformate
501-53-1

benzyl chloroformate

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

4-azido-N-benzyloxycarbonyl-1-butylamine
123348-73-2

4-azido-N-benzyloxycarbonyl-1-butylamine

Conditions
ConditionsYield
With sodium hydroxide In tetrahydrofuran; water at 0 - 20℃; for 12h;100%
2-Nitrobenzenesulfonyl chloride
1694-92-4

2-Nitrobenzenesulfonyl chloride

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

N-(4-azido-butyl)-2-nitro-benzenesulfonamide

N-(4-azido-butyl)-2-nitro-benzenesulfonamide

Conditions
ConditionsYield
With sodium hydroxide In tetrahydrofuran; water100%
p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

N-(4-azido-butyl)-4-methyl-benzenesulfonamide

N-(4-azido-butyl)-4-methyl-benzenesulfonamide

Conditions
ConditionsYield
With sodium hydroxide In tetrahydrofuran; water100%
2-hydroxy-2-methylpropanenitrile
75-86-5

2-hydroxy-2-methylpropanenitrile

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

2-(4-azidobutylamino)-2-methylpropionitrile
1220428-56-7

2-(4-azidobutylamino)-2-methylpropionitrile

Conditions
ConditionsYield
With sodium sulfate at 21℃; for 12h; Inert atmosphere;99%
3-acetylenephenylamine
54060-30-9

3-acetylenephenylamine

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

1-(4-aminobutyl)-4-(3-aminophenyl)-1H-1,2,3-triazole

1-(4-aminobutyl)-4-(3-aminophenyl)-1H-1,2,3-triazole

Conditions
ConditionsYield
With copper(II) sulfate; sodium L-ascorbate95%
indomethacin pentafluorophenyl ester
65360-26-1

indomethacin pentafluorophenyl ester

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

N-(4-azidobut-1-yl)indomethacin amide

N-(4-azidobut-1-yl)indomethacin amide

Conditions
ConditionsYield
In dichloromethane at 20℃; for 2h; Inert atmosphere;94%
oxalic acid
144-62-7

oxalic acid

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

4-azidobutylamine hemioxalate

4-azidobutylamine hemioxalate

Conditions
ConditionsYield
In ethanol for 0.5h;94%
1,2-bis(bromomethyl)-4,5-dimethoxybenzene
26726-81-8

1,2-bis(bromomethyl)-4,5-dimethoxybenzene

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

2-(4-azidobutyl)-5,6-dimethoxyisoindoline
1285549-10-1

2-(4-azidobutyl)-5,6-dimethoxyisoindoline

Conditions
ConditionsYield
With potassium carbonate; sodium iodide In N,N-dimethyl-formamide at 60℃; for 3h;93%
vancomycin
1404-90-6

vancomycin

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

C70H83Cl2N13O23

C70H83Cl2N13O23

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dimethyl sulfoxide; N,N-dimethyl-formamide at 0 - 23℃;93%
cholic acid
81-25-4

cholic acid

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

4-azidobutylamine cholate

4-azidobutylamine cholate

Conditions
ConditionsYield
In tert-butyl methyl ether at 20 - 25℃; for 16h;92%
N-(prop-2-ynyl)-2-(4-(trifluoromethyl)phenyl)diazenecarboxamide
1224434-04-1

N-(prop-2-ynyl)-2-(4-(trifluoromethyl)phenyl)diazenecarboxamide

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

N-((1-(4-aminobutyl)-1H-1,2,3-triazol-4-yl)methyl)-2-(4-(trifluoromethyl)phenyl)diazenecarboxamide
1224434-34-7

N-((1-(4-aminobutyl)-1H-1,2,3-triazol-4-yl)methyl)-2-(4-(trifluoromethyl)phenyl)diazenecarboxamide

Conditions
ConditionsYield
With copper(ll) sulfate pentahydrate In methanol; water at 20℃; for 0.0833333h; Inert atmosphere; regioselective reaction;91%
2',3'-O-isopropylideneinosine
2140-11-6

2',3'-O-isopropylideneinosine

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

N6-(4
1616876-08-4

N6-(4"-azidobutyl)-2',3'-(O-isopropylidene)adenosine

Conditions
ConditionsYield
With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In acetonitrile Inert atmosphere;91%
2',3'-O-isopropylidene inosine
2140-11-6

2',3'-O-isopropylidene inosine

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

N6-(4
1616876-08-4

N6-(4"-azidobutyl)-2',3'-(O-isopropylidene)adenosine

Conditions
ConditionsYield
Stage #1: 2',3'-O-isopropylidene inosine With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; Inert atmosphere;
Stage #2: 4-azidobutan-1-amine In acetonitrile at 20℃; Inert atmosphere;
91%
(±)-10-camphorsulphonic acid

(±)-10-camphorsulphonic acid

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

4-azidobutylamine camphorsulphonate

4-azidobutylamine camphorsulphonate

Conditions
ConditionsYield
In tert-butyl methyl ether at 20 - 25℃; for 16h;91%
4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

putrescine dihydrochloride
333-93-7

putrescine dihydrochloride

Conditions
ConditionsYield
With hydrogenchloride; hydrogen; palladium on activated charcoal In methanol under 3102.9 Torr; for 18h; Ambient temperature;90%
4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

4-(1-pyrene)butyric acid N-hydroxysuccinimide ester
114932-60-4

4-(1-pyrene)butyric acid N-hydroxysuccinimide ester

4-(pyren1-yl)butanoic acid N-4-azidobutylamide

4-(pyren1-yl)butanoic acid N-4-azidobutylamide

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 3h;88%
ethacrynic acid
58-54-8

ethacrynic acid

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

1-{4-[(4-azidobutylaminooxy)methyl]-2,3-dichlorophenyl}-2-methylenebutan-1-one
1284258-80-5

1-{4-[(4-azidobutylaminooxy)methyl]-2,3-dichlorophenyl}-2-methylenebutan-1-one

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide for 1h; Inert atmosphere;86%
fluoresceinyl 5-isothiocyanate
1173-43-9

fluoresceinyl 5-isothiocyanate

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

1-(4-azidobutyl)-3-(6'-hydroxy-3,3'-dioxo-3',9a'-dihydro-3H-spiro[isobenzofuran-1,9'-xanthen]-6-yl)thiourea

1-(4-azidobutyl)-3-(6'-hydroxy-3,3'-dioxo-3',9a'-dihydro-3H-spiro[isobenzofuran-1,9'-xanthen]-6-yl)thiourea

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 20℃; for 12h;86%
Cholesteryl chloroformate
7144-08-3

Cholesteryl chloroformate

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

C32H54N4O2

C32H54N4O2

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 20℃; for 18h;82%
3-(p-phenyl)benzoylpropionic acid
36330-85-5

3-(p-phenyl)benzoylpropionic acid

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

N-(4-azidobutyl)-4-(biphenyl-4-yl)-4-oxobutanamide
1284258-78-1

N-(4-azidobutyl)-4-(biphenyl-4-yl)-4-oxobutanamide

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide for 1h; Inert atmosphere;77%
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 60℃; for 1h;77%
4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

5'(S)-[O4-(2,4,6-triisopropylbenzenesulfonyl)uracil-1-yl]-1',3'-oxathiolane-2'(R)-carboxylic acid (1R,2S,5R)-menthyl ester
389128-29-4

5'(S)-[O4-(2,4,6-triisopropylbenzenesulfonyl)uracil-1-yl]-1',3'-oxathiolane-2'(R)-carboxylic acid (1R,2S,5R)-menthyl ester

5'(S)-{N4-[1-(4-azidobutyl)]cytosin-1-yl}-1',3'-oxathiolane-2'(R)-carboxylic acid (1R,2S,5R)-menthyl ester
389128-30-7

5'(S)-{N4-[1-(4-azidobutyl)]cytosin-1-yl}-1',3'-oxathiolane-2'(R)-carboxylic acid (1R,2S,5R)-menthyl ester

Conditions
ConditionsYield
In dichloromethane at 0℃; for 0.75h;76%
O,O'-dibenzoyl-D-tartaric acid
17026-42-5

O,O'-dibenzoyl-D-tartaric acid

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

4-azidobutylamine dibenzoyl-L-tartrate

4-azidobutylamine dibenzoyl-L-tartrate

Conditions
ConditionsYield
In tert-butyl methyl ether at 20 - 25℃; for 16h;75%
C34H52FN3O10

C34H52FN3O10

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

C35H58FN5O10

C35H58FN5O10

Conditions
ConditionsYield
In water; acetonitrile at 55 - 65℃;75%
4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

(R)-1,2-dithiolane-3-pentanoic acid
1200-22-2

(R)-1,2-dithiolane-3-pentanoic acid

C12H22N4OS2

C12H22N4OS2

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In tetrahydrofuran at 0 - 20℃;75%
(1'S,2'R,3'S,4'R,5'S)-4'-[6-(3-chlorobenzylamino)-2-(1,7-octadiynyl)-9H-purin-9-yl]-2',3'-dihydroxybicyclo[3.1.0]hexane-1'-carboxylic acid N-methylamide
1213770-15-0

(1'S,2'R,3'S,4'R,5'S)-4'-[6-(3-chlorobenzylamino)-2-(1,7-octadiynyl)-9H-purin-9-yl]-2',3'-dihydroxybicyclo[3.1.0]hexane-1'-carboxylic acid N-methylamide

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

(1S,2R,3S,4R,5S)-4-(6-(3-chlorobenzylamino)-2-(6-(1-(4-aminobutyl)-1H-1,2,3-triazol-4-yl)hex-1-ynyl)-9H-purin-9-yl)-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxylic acid N-methylamide
1217299-63-2

(1S,2R,3S,4R,5S)-4-(6-(3-chlorobenzylamino)-2-(6-(1-(4-aminobutyl)-1H-1,2,3-triazol-4-yl)hex-1-ynyl)-9H-purin-9-yl)-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxylic acid N-methylamide

Conditions
ConditionsYield
With copper(II) sulphate hydrate; sodium L-ascorbate; tris[(1-benzyl-1H-1,2,3-triazol-4yl)methyl]amine In water; tert-butyl alcohol at 20℃; regioselective reaction;73%
4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

4-azido-1-butanol
54953-78-5

4-azido-1-butanol

Conditions
ConditionsYield
With sodium azide; trifluoromethylsulfonic anhydride In dichloromethane; water70%
thiophene-2-carbaldehyde
98-03-3

thiophene-2-carbaldehyde

4-azidobutan-1-amine
88192-20-5

4-azidobutan-1-amine

4-azido-N-(thiophen-2-ylmethyl)butan-1-amine

4-azido-N-(thiophen-2-ylmethyl)butan-1-amine

Conditions
ConditionsYield
Stage #1: thiophene-2-carbaldehyde; 4-azidobutan-1-amine With triethylamine In methanol for 12h; Inert atmosphere; Reflux;
Stage #2: With sodium tetrahydroborate In methanol at 0℃; for 1h; Inert atmosphere;
70%

88192-20-5Relevant academic research and scientific papers

Carba-cyclophellitols Are Neutral Retaining-Glucosidase Inhibitors

Beenakker, Thomas J. M.,Wander, Dennis P. A.,Offen, Wendy A.,Artola, Marta,Raich, Lluís,Ferraz, Maria J.,Li, Kah-Yee,Houben, Judith H. P. M.,Van Rijssel, Erwin R.,Hansen, Thomas,Van Der Marel, Gijsbert A.,Codée, Jeroen D. C.,Aerts, Johannes M. F. G.,Rovira, Carme,Davies, Gideon J.,Overkleeft, Herman S.

, p. 6534 - 6537 (2017)

The conformational analysis of glycosidases affords a route to their specific inhibition through transition-state mimicry. Inspired by the rapid reaction rates of cyclophellitol and cyclophellitol aziridine - both covalent retaining β-glucosidase inhibitors - we postulated that the corresponding carba cyclopropyl analogue would be a potent retaining β-glucosidase inhibitor for those enzymes reacting through the 4H3 transition-state conformation. Ab initio metadynamics simulations of the conformational free energy landscape for the cyclopropyl inhibitors show a strong bias for the 4H3 conformation, and carba-cyclophellitol, with an N-(4-azidobutyl)carboxamide moiety, proved to be a potent inhibitor (Ki = 8.2 nM) of the Thermotoga maritima TmGH1 β-glucosidase. 3-D structural analysis and comparison with unreacted epoxides show that this compound indeed binds in the 4H3 conformation, suggesting that conformational strain induced through a cyclopropyl unit may add to the armory of tight-binding inhibitor designs.

Photoswitchable CAR-T Cell Function In Vitro and In Vivo via a Cleavable Mediator

Zhang, Bo,Wang, Yan,Huang, Shenlong,Sun, Jiaqi,Wang, Min,Ma, Wenxiao,You, Yanbo,Wu, Ling,Hu, Jin,Song, Wei,Liu, Xudong,Li, Shengjie,Chen, Hua,Zhang, Guisheng,Zhang, Lihe,Zhou, Demin,Li, Lingjun,Zhang, Xuan

, p. 60 - 7,69 (2020/12/07)

Chimeric antigen receptor (CAR)-T-based therapeutics are a breakthrough in cancer treatment; however, they are hampered by constitutive activation, which leads to worrisome side effects. Engineering CAR-T cells to be as tightly controllable as possible remains a topic of ongoing investigation. Here, we report a photoswitchable approach that uses a mediator for the at-will regulation of CAR-T cells. This mediator carries dual folate and fluorescein isothiocyanate moieties tethered by an ortho-nitrobenzyl ester photocleavable linker. CAR-T cells were shown to be highly cytotoxic to targeted cells only in the presence of the mediator and acted in a dose-dependent manner. The toxicity of CAR-T cells can be rapidly terminated by cleavage of the mediator, and the effects of CAR-T cells can be activated again by resupplementation with the mediator without compromising tumor therapy. The approach described here provides a direction for enhancing the controllability of CAR-T cells and can likely be applied in other immunotherapies.CAR-T is a powerful technology for cancer therapy, but is largely limited by inherent controllability issues. Zhang et al. developed an accurate controllable approach based on the bond-cleavage chemistry combined with universal anti-FITC CAR-T cells, allowing the regulation of CAR-T cells in a switchable manner.

Design and synthesis of a bis-macrocyclic host and guests as building blocks for small molecular knots

Fenlon, Edward E.,Keyes, Rebecca J.,Lockey, Stephen D.,Margolis, Elizabeth A.

supporting information, p. 2314 - 2321 (2020/10/14)

The thread-link-cut (TLC) approach has previously shown promise as a novel method to synthesize molecular knots. The modular second-generation approach to small trefoil knots described herein involves electrostatic interactions between an electron-rich bismacrocyclic host compound and electron-deficient guests in the threading step. The bis-macrocyclic host was synthesized in eight steps and 6.6% overall yield. Ammonium and pyridinium guests were synthesized in 4-5 steps. The TLC knot-forming sequence was carried out and produced a product with the expected molecular weight, but, unfortunately, further characterization did not produce conclusive results regarding the topology of the product.

Fe(III)-Catalyzed Aerobic Intramolecular N-N Coupling of Aliphatic Azides with Amines

Zhang, Yue,Duan, Dongyu,Zhong, Ying,Guo, Xin-Ai,Guo, Jiawei,Gou, Jing,Gao, Ziwei,Yu, Binxun

supporting information, p. 4960 - 4965 (2019/09/03)

An Fe(III)-catalyzed intramolecular N-N coupling of aliphatic azidoamines that forms diverse five- and six-membered semisaturated diazoheterocycles using air as an oxidant is reported, providing an alternative to hydrazine-based methods. Mechanistic studies suggest that a N-radical induced intramolecular homolytic substitution (SH2) is involved in ring closure. The power of this N-N bond-forming method is also demonstrated by using it as the final step in a total synthesis of (-)-newbouldine.

For the control of the chimeric antigen receptor of the T cell activation/inhibit the connecting arm and its application (by machine translation)

-

Paragraph 0020; 0031; 0034, (2019/01/23)

The invention discloses a method for control CAR - T/inhibit the activation of the link arm, and one end of the cells containing the target [...] molecule, the other at one end and can be specific CAR - T cell identified with biological orthogonality of the part, and the middle of the can be biological orthogonal fracture chemical group coupling. This invention can realize the CAR - T cell from active to a resting state fast and flexible conversion, to CAR - T cell inhibiting the systematic and high efficiency. Adjusting has reversibility, not damage or kill some CAR - T cell, can realize the CAR - T cell from active to close and then to activate the flexible change, the overall functions of the treatment is not affected. (by machine translation)

Traceless Templated Amide-Forming Ligations

Osuna Gálvez, Alberto,Bode, Jeffrey W.

supporting information, p. 8721 - 8726 (2019/06/13)

Template assistance allows organic reactions to occur under highly dilute conditions - where intermolecular reactions often fail to proceed - by bringing reactants into close spatial proximity. This strategy has been elegantly applied to numerous systems, but always with the retention of at least one of the templating groups in the product. In this report, we describe a traceless, templated amide-forming ligation that proceeds at low micromolar concentration under aqueous conditions in the presence of biomolecules. We utilized the unique features of an acylboronate-hydroxylamine ligation, in which covalent bonds are broken in each of the reactants as the new amide bond is formed. By using streptavidin as a template and acylboronates and O-acylhydroxylamines bearing desthiobiotins that are cleaved upon amide formation, we demonstrate that traceless, templated ligation occurs rapidly even at submicromolar concentrations. The requirement for a close spatial orientation of the functional groups - achieved upon binding to streptavidin - is critical for the observed enhancement in the rate and quantity of product formed.

Novel menadione hybrids: Synthesis, anticancer activity, and cell-based studies

Prasad, Chakka Vara,Nayak, Vadithe Lakshma,Ramakrishna, Sistla,Mallavadhani, Uppuluri Venkata

, p. 220 - 233 (2017/12/29)

A series of novel menadione-based triazole hybrids were designed and synthesized by employing copper-catalyzed azide-alkyne cycloaddition (CuAAC). All the synthesized hybrids were characterized by their spectral data (1H NMR, 13C NMR, IR, and HRMS). The synthesized compounds were evaluated for their anticancer activity against five selected cancer cell lines including lung (A549), prostate (DU-145), cervical (Hela), breast (MCF-7), and mouse melanoma (B-16) using MTT assay. The screening results showed that majority of the synthesized compounds displayed significant anticancer activity. Among the tested compounds, the triazoles 5 and 6 exhibited potent activity against all cell lines. In particular, compound 6 showed higher potency than the standard tamoxifen and parent menadione against MCF-7 cell line. Flow cytometric analysis revealed that compound 6 arrested cell cycle at G0/G1 phase and induced apoptotic cell death which was further confirmed by Hoechst staining, measurement of mitochondrial membrane potential (ΔΨm) and Annexin-V-FITC assay. Thus, compound 6 can be considered as lead molecule for further development as potent anticancer therapeutic agent.

Method for producing azido-amine derivative

-

Page/Page column 5; 6, (2018/03/25)

A method for producing an azido-amine derivative includes obtaining an azido-amine derivative and extracting the azido-amine derivative obtained by using an aromatic solvent or an ether solvent.

A fullerene helical peptide: synthesis, characterization and formation of self-assembled monolayers on gold surfaces

Nasrallah, Houssein,Rabah, Jad,Bui-Thi-Tuyet, Van,Baczko, Krystyna,Fensterbank, Hélène,Bourdreux, Flavien,Goncalves, Anne-Marie,Declerck, Valérie,Boujday, Souhir,Humblot, Vincent,Wright, Karen,Vallée, Anne,Allard, Emmanuel

supporting information, p. 19423 - 19432 (2018/12/13)

The synthesis of a C60-peptide using “clickable” fullerene and peptide derivatives is described. The peptide is composed of a repeating sequence of α-aminoisobutyric acid (Aib) and two l-alanine (Ala) residues, promoting the formation of a helical conformation, which has been confirmed by IR absorption, NMR and circular dichroism measurements. In addition, the presence of a lipoyl moiety, at the end of the peptide sequence, allows the formation of self-assembled monolayers of the C60-peptide and the parent peptide on a gold surface. A C60-alkyl derivative was also prepared to compare the self-assembly properties of fullerene derivatives containing peptides or alkyl chains. The fullerene assembly on a gold substrate characterized by quartz crystal microbalance and by cyclic voltammetry show that the monolayers containing alkyl chains are slightly less well packed than the peptide monolayers. Finally, polarization modulation reflection adsorption infra-red spectroscopy measurements indicate that the C60-peptide tends to be more vertical than the parent peptide which could originate from complementary C60-C60 and helical-helical interactions.

METHOD OF PRODUCING AZIDAMINE DERIVATIVES

-

Paragraph 0024, (2016/10/07)

PROBLEM TO BE SOLVED: To provide a method of producing azidamine derivatives that overcome problems such as deterioration with time and safety and enables mass production on an industrial scale. SOLUTION: A method of producing azidamine derivatives comprises the steps of obtaining azidamine derivatives and extracting the obtained azidamine derivatives with an aromatic solvent or an ether solvent. SELECTED DRAWING: None COPYRIGHT: (C)2016,JPOandINPIT

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 88192-20-5